Sandoz Can't Expand Xarelto Damages Claim Against Bayer
A London court said Tuesday that Bayer's mindset in seeking interim injunctions to protect its now-revoked patent for the blood-thinning drug Xarelto "makes no difference" to Sandoz's claim for damages, refusing...To view the full article, register now.
Already a subscriber? Click here to view full article